1. Home
  2. LLY

as 02-10-2025 4:00pm EST

$
-
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.

Founded: 1876 Country:
United States
United States
Employees: N/A City: INDIANAPOLIS
Market Cap: 770.9B IPO Year: N/A
Target Price: $976.43 AVG Volume (30 days): 4.2M
Analyst Decision: Strong Buy Number of Analysts: 22
Dividend Yield:
0.69%
Dividend Payout Frequency: Quarterly
EPS: 11.71 EPS Growth: 101.90
52 Week Low/High: $711.40 - $972.53 Next Earning Date: 02-06-2025
Revenue: $45,042,700,000 Revenue Growth: 32.00%
Revenue Growth (this year): 32.76% Revenue Growth (next year): 17.58%

LLY Daily Stock ML Predictions

Share on Social Networks:

Similar to LLY Stocks: